| Tissue | Methodology | PMID |
|---|---|---|
| Brain | Northern blot | 12743596 |
| Placenta | Northern blot | 12743596 |
| Heart | Northern blot | 12743596 |
| Skeletal muscle | Northern blot | 12743596 |
| Testis | qRT-PCR | 19542363 |
| Brain | qRT-PCR | 19542363 |
| Lung | qRT-PCR | 19542363 |
| Brain | Northern blot | 10600548 |
| Skeletal muscle | Northern blot | 10600548 |
Hematologic malignacies Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Myeloma |
13/64 (20%) | Affymetrix array | 19542363 | |
| Myeloma |
Newly diagnosed patient | 296/320 (92%) | Microarray | 21738656 |
| Myeloma |
Relapse patient | 94/264 (36%) | Microarray |
Brain cancer Show
| Tumor Subtype | Sample type | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Brain tumor |
3/54 (6%) | qRT-PCR | 12743596 |
| Origin tissue | Cell Line ID | Frequency | Methodology | PMID |
|---|---|---|---|---|
| Brain tumor | U343 T98G U118 U183 |
Northern blot | 12743596 | |
| Breast carcinoma | MDA-MB-436 MDA-MB-231 MCF-7 |
Northern blot | 12743596 | |
| Glioblastoma | A172 | Northern blot | 10600548 | |
| Hepatoma | HepG2 | Northern blot | 12743596 | |
| Leukemia | U937 | Northern blot | 12743596 | |
| Lung carcinoma | NCIH446 NCI-H526 NCIH125 NCI-H1299 NCI-H157 NCI-H520 NCI-H157 |
Northern blot | 12743596 | |
| Pancreatic carcinoma | PANC-1 | Northern blot | 12743596 | |
| Prostate cancer | DU145 PC3 |
Northern blot | 12743596 |
2005-2009© CT Antigens Database